Skin News and Research

RSS

FDA approves first intravenous treatment for metastatic cutaneous squamous cell carcinoma

The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squamous cell carcinoma or locally advanced CSCC who are not candidates for curative surgery or curative radiation.

28 Sep 2018

Acne stigma associated with impaired psychological and physical well-being

Many people with acne are negatively impacted by perceived social stigma around the skin condition, a new study from University of Limerick, Ireland, has found.

28 Sep 2018

Researchers decipher antitumor mechanism of Amazonian plant in human cancer cells

A piece of research conducted by the Free Radicals and Oxidative Stress Group at the UPV/EHU's Faculty of Medicine and Nursing has deciphered the antitumor mechanism exerted by the plant Vismia baccifera, originally from the Amazonian region of Colombia, in human liver cancer cells.

28 Sep 2018

Taken for a ride: After ATV crash, doctor gets $56,603 bill for air ambulance trip

It was the first — and only — time Dr. Naveed Khan, a 35-year-old radiologist, ever rode in an all-terrain vehicle.

28 Sep 2018

Synthetic DNA vaccine targets proteins overexpressed in several types of cancer

Scientists at The Wistar Institute have implemented a novel structurally designed synthetic DNA vaccine to simultaneously target multiple members of a family of proteins that are specifically overexpressed in several types of cancer.

28 Sep 2018

Researchers develop unique, biofuel-powered sensor to prevent and diagnose diseases

Researchers at Washington State University have developed an implantable, biofuel-powered sensor that runs on sugar and can monitor a body's biological signals to detect, prevent and diagnose diseases.

28 Sep 2018

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved VIZIMPRO [vih-ZIM-pro] (dacomitinib), a kinase inhibitor for the first-line treatment of patients with metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletion or exon 21 L858R substitution mutations as detected by an FDA-approved test.

28 Sep 2018

Parents are leery of schools requiring ‘mental health’ disclosures by students

Children registering for school in Florida this year were asked to reveal some history about their mental health.

27 Sep 2018

Normal skin is more resilient to cancer than previously thought

Normal skin contains a patchwork of mutated cells, yet very few go on to eventually form cancer and scientists have now uncovered the reason why. Researchers at the Wellcome Sanger Institute and MRC Cancer Unit, University of Cambridge genetically engineered mice to show that mutant cells in skin tissue compete with each other, with only the fittest surviving.

27 Sep 2018

FLX Bio treats first patient in its Phase 1/2 clinical trial of FLX475 for treating various advanced cancers

FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.

27 Sep 2018

Cornwall and Chongqing Haifu partners to introduce HIFU tumor therapy system

Cornwall Medical Group enters a strategic partnership with the world's leading medical equipment and integrated solutions provider, Chongqing Haifu Medical Technology Co., Ltd., to introduce innovative high-intensity focused ultrasound tumor therapy system to Hong Kong, positioned to be the first minimally-invasive & non-invasive center in town.

27 Sep 2018

Not all P53 mutations cause skin cancer

Today, scientists have explained for the first time why not all UV-induced, P53 mutated skin cells develop into cancer.

27 Sep 2018

AVITA Medical announces results revealing safety, effectiveness of RECELL System for burn care

AVITA Medical , a global regenerative medicine company, today announced that the results from two U.S. pivotal clinical trials demonstrating the effectiveness and clinical benefits of the RECELL Autologous Cell Harvesting Device were presented at the 46th Annual Eastern Great Lakes Burn Conference in Ann Arbor, Michigan.

27 Sep 2018

Skin News and Research

FDA approves first intravenous treatment for metastatic cutaneous squamous cell carcinoma

Acne stigma associated with impaired psychological and physical well-being

Researchers decipher antitumor mechanism of Amazonian plant in human cancer cells

Taken for a ride: After ATV crash, doctor gets $56,603 bill for air ambulance trip

Synthetic DNA vaccine targets proteins overexpressed in several types of cancer

Researchers develop unique, biofuel-powered sensor to prevent and diagnose diseases

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Parents are leery of schools requiring ‘mental health’ disclosures by students

Normal skin is more resilient to cancer than previously thought

FLX Bio treats first patient in its Phase 1/2 clinical trial of FLX475 for treating various advanced cancers

Cornwall and Chongqing Haifu partners to introduce HIFU tumor therapy system

Not all P53 mutations cause skin cancer

AVITA Medical announces results revealing safety, effectiveness of RECELL System for burn care

Study explores demographic, socioeconomic patterns linked with use of dermatologic services

Researchers take first steps in developing 'paintable' chemotherapy for melanoma

Cocoa: New, previously unknown source of vitamin D2 identified

New study reveals surprising link between gut microbiota and skin allergies

IQWiG recommends update in health care aspects of DMP ‘type 1 diabetes’

Paralyzed man regains his ability to stand, walk with spinal cord stimulation and physical therapy

BetterYou receives double accolade at Janey Loves Platinum Awards 2018

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News